Holen Sie sich die Stockscreener-App
3.23
0.62%
-0.02
Handel nachbörslich:
3.22
-0.010
-0.31%
Finanzdaten der Oncology Institute Inc-Aktie (TOI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.13%
104.41
|
100.27 | 99.90 | 98.58 | 94.67 |
Operating Expenses
|
1.89%
114.32
|
112.20 | 113.75 | 114.94 | 112.64 |
| Benefits Costs and Expenses |
9.29%
123.99
|
113.45 | 116.01 | 114.06 | 114.56 |
| Costs And Expenses |
9.29%
123.99
|
113.45 | 116.01 | 114.06 | 114.56 |
| Depreciation and Amortization |
4.51%
1.784
|
1.707 | 1.573 | 1.518 | 1.489 |
| Operating Income/Loss |
16.92%
-9.911
|
-11.93 | -13.85 | -16.36 | -17.97 |
| Nonoperating Income/Loss |
672.07%
-9.674
|
-1.253 | -2.26 | 0.885 | -1.917 |
| Income/Loss From Continuing Operations Before Tax |
48.57%
-19.59
|
-13.18 | -16.11 | -15.48 | -19.89 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
48.57%
-19.59
|
-13.18 | -16.11 | -15.48 | -19.89 |
|
Net Income/Loss
|
48.57%
-19.59
|
-13.18 | -16.11 | -15.48 | -19.89 |
| Preferred Stock Dividends And Other Adjustments |
48.98%
-3.51
|
-2.356 | -2.89 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
37,447%
77.10
|
0.2053 | 75.52 | 74.75 | 74.23 |
| Diluted Average Shares |
37,447%
77.10
|
0.2053 | 75.52 | 74.75 | 74.23 |
| Basic Earnings Per Share |
40.00%
-0.21
|
-0.15 | -0.18 | -0.17 | -0.22 |
| Diluted Earnings Per Share |
40.00%
-0.21
|
-0.15 | -0.18 | -0.17 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
48.98%
-3.51
|
-2.356 | -2.89 | -2.80 | -3.617 |
0.21%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):